Results
71,130 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 8 |  Kurtz GeorgeDirector, PRESIDENT AND CEO |  CRWDCrowdStrike Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $45K 170 sh |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 8 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $45K 170 sh |
| Oct 29, 2026 traded Oct 27, 2026 |
| 8 | Wang XiaodongDirector, Chair, Scientific Advisory Brd |  ONCBeOne Medicines Ltd.Open-market sale · 10b5-1 plan | SELL | $603K 1,681 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 8 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $36K 134 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 8 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $44K 163 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 8 | Bradshaw RichardEVP, Chief Banking Officer |  UCBUNITED COMMUNITY BANKS INCGift | G | — 395 sh | Oct 29, 2026 traded Oct 29, 2026 |
| 7 | Buczkowski MichelleChief Commercial Officer |  EOSEEos Energy Enterprises, Inc.Option exercise · 10b5-1 plan | M | — 100.0K sh | Oct 29, 2026 traded Oct 28, 2026 |
| 6 | Mensinger MikeChief Product Officer |  BBNXBeta Bionics, Inc.Open-market sale · 10b5-1 plan | SELL | $58K 2,650 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 6 | Bentley Sheldon RichardFounder |  CSAICLOUDASTRUCTURE, INC.Open-market sale · 10b5-1 plan | SELL | $3,405 1,500 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 6 | Cheng Chi FungDirector, Chief Technology Officer |  CRDOCredo Technology Group Holding LtdOpen-market sale · 10b5-1 plan | SELL | $84K 500 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 6 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $94K 600 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 6 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $131K 800 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 6 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $81K 500 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 5 | Starke JeffEVP, CHIEF INFORMATION OFFICER |  RBCAAREPUBLIC BANCORP INC /KY/Tax withholding | F | $276 3 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 5 | Olson AnneliesePres Imaging Prtng & Solutions |  HPQHP INCOption exercise | M | — 29.1K sh | Oct 29, 2026 traded Oct 27, 2026 |
| 5 | Starke JeffEVP, CHIEF INFORMATION OFFICER | RBCAAREPUBLIC BANCORP INC /KY/ Grant or award | A | — 10 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 5 | Starke JeffEVP, CHIEF INFORMATION OFFICER | RBCAAREPUBLIC BANCORP INC /KY/ Option exercise | M | — 6,720 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 5 | Rhodes Coolidge E JRGroup EVP General Counsel/Sec |  CFRCULLEN/FROST BANKERS, INC.Grant or award | A | — 3,522 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 5 | O'Brien Kevin PatrickChief Financial Officer |  HYFMHYDROFARM HOLDINGS GROUP, INC.Grant or award | A | — 55.2K sh | Oct 29, 2026 traded Oct 27, 2026 |
| 5 | Pullin Ericka LynnGEVP, Culture & People Dev. | CFRCULLEN/FROST BANKERS, INC. Grant or award | A | — 1,666 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 4 | Rubinstein JuliePresident and COO |  ADPTAdaptive Biotechnologies CorpOpen-market sale · 10b5-1 plan | SELL | $332K 11.7K sh | Oct 29, 2026 traded Oct 28, 2026 |
| 4 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | ONCBeOne Medicines Ltd. Open-market sale · 10b5-1 plan | SELL | $460K 1,280 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 4 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | ONCBeOne Medicines Ltd. Open-market sale · 10b5-1 plan | SELL | $443K 1,239 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 4 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $336K 11.9K sh | Oct 29, 2026 traded Oct 29, 2026 |
| 4 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | ONCBeOne Medicines Ltd. Open-market sale · 10b5-1 plan | SELL | $313K 880 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 4 | Boughton SoleilChief Legal Officer |  HIMSHims & Hers Health, Inc.Open-market sale · 10b5-1 plan | SELL | $96K 3,462 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 4 | Eisen Anthony MathewDirector |  XYZBlock, Inc.Open-market sale · 10b5-1 plan | SELL | $447K 6,000 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 4 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | ONCBeOne Medicines Ltd. Open-market sale · 10b5-1 plan | SELL | $512K 1,440 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 3 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $32K 200 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 3 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $48K 300 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 3 | Twomey Christopher JDirector |  TNDMTANDEM DIABETES CARE INCOption exercise · 10b5-1 plan | M | $32K 1,700 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 3 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $31K 200 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 1 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $244K 8,881 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 1 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $80K 3,000 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 1 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | ONCBeOne Medicines Ltd. Option exercise · 10b5-1 plan | M | $1.14M 31.0K sh | Oct 29, 2026 traded Oct 27, 2026 |
| 1 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | ONCBeOne Medicines Ltd. Open-market sale · 10b5-1 plan | SELL | $115K 320 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Oct 29, 2026 traded Oct 28, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Oct 29, 2026 traded Oct 27, 2026 |
| 0 | Hafer EvanDirector, Founder, 10% Owner |  BRCCBRC Inc.Derivative conversion · 10b5-1 plan | C | — 12.0K sh | Oct 29, 2026 traded Oct 28, 2026 |
| 0 | Hafer EvanDirector, Founder, 10% Owner | BRCCBRC Inc. Derivative conversion · 10b5-1 plan | C | — 12.0K sh | Oct 29, 2026 traded Oct 28, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $5,780 200 sh | Oct 29, 2026 traded Oct 28, 2026 |